scholarly article | Q13442814 |
P356 | DOI | 10.1016/0092-8674(83)90344-6 |
P698 | PubMed publication ID | 6678608 |
P2093 | author name string | Baltimore D | |
Mulligan RC | |||
Mann R | |||
P2860 | cites work | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 |
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
SV40-transformed simian cells support the replication of early SV40 mutants | Q28263905 | ||
Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase | Q35237118 | ||
Transfer of defective avian tumor virus genomes by a Rous sarcoma virus RNA packaging mutant | Q35237388 | ||
Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1 | Q35241541 | ||
Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus | Q36494740 | ||
Virus-Like 30S RNA in Mouse Cells | Q36495367 | ||
gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms | Q36498177 | ||
Evidence for the Identity of Shared 5′-Terminal Sequences Between Genome RNA and Subgenomic mRNA's of B77 Avian Sarcoma Virus | Q36505167 | ||
Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus | Q36507479 | ||
Adaptation of a Retrovirus as a Eucaryotic Vector Transmitting the Herpes Simplex Virus Thymidine Kinase Gene | Q36972460 | ||
Interactions of Murine Leukemia Virus Core Components: Characterization of Reverse Transcriptase Packaged in the Absence of 70S Genomic RNA | Q37507683 | ||
High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures | Q37602288 | ||
Analysis of a 5' leader sequence on murine leukemia virus 21S RNA: heteroduplex mapping with long reverse transcriptase products | Q39490825 | ||
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections | Q39505489 | ||
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: Biological and biochemical characterization | Q39523411 | ||
Multiple Free Viral DNA Copies in Polyoma Virus-Transformed Mouse Cells Surviving Productive Infection | Q39978361 | ||
Form and Function of Retroviral Proviruses | Q40103422 | ||
Expression of a Bacterial Gene in Mammalian Cells | Q43823296 | ||
Structure of viral DNA and RNA in mammalian cells infected with avian sarcoma virus | Q45802199 | ||
Nucleotide sequence of Moloney murine leukaemia virus | Q45805458 | ||
Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles | Q45820129 | ||
Germ line integration of moloney leukemia virus: effect of homozygosity at the m-mulV locus | Q45886973 | ||
Chromosomal position and activation of retroviral genomes inserted into the germ line of mice | Q53571340 | ||
Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences | Q59064680 | ||
49 Rapid DNA isolations for enzymatic and hybridization analysis | Q72850821 | ||
P4510 | describes a project that uses | Psi-2 | Q54948492 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
P304 | page(s) | 153-159 | |
P577 | publication date | 1983-05-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus | |
P478 | volume | 33 |
Q36938516 | A 36-base-pair core sequence of locus control region enhances retrovirally transferred human beta-globin gene expression |
Q26741371 | A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells |
Q36645272 | A Friend virus mutant that overcomes Fv-2rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors. |
Q40231134 | A HIV-2-based self-inactivating vector for enhanced gene transduction |
Q41343719 | A NIH/3T3 cell line stably expressing human cytochrome P450-3A4 used in combination with a lacZ' shuttle vector to study mutagenicity |
Q42465408 | A Novel Monoclonal Antibody against Squamous Cell Carcinoma |
Q35222291 | A brief history of gene therapy |
Q33822395 | A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. |
Q40966190 | A cell type-specific constitutive point mutant of the common beta-subunit of the human granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5 receptors requires the GM-CSF receptor alpha-subunit for activation |
Q36809489 | A colony-stimulating factor 1 (CSF-1) receptor/platelet-derived growth factor-beta receptor gene fusion confers CSF-1 independence and tumorigenicity on a c-myc-immortalized monocyte cell line |
Q36831879 | A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization |
Q40127033 | A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging |
Q44361863 | A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines. |
Q40520186 | A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses |
Q40428153 | A defective HIV-1 vector for gene transfer to human lymphocytes |
Q43244050 | A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons |
Q37628572 | A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. |
Q39877131 | A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis |
Q33559130 | A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor |
Q36763465 | A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells |
Q77871519 | A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins |
Q36864589 | A mouse c-myc retrovirus transforms established fibroblast lines in vitro and induces monocyte-macrophage tumors in vivo |
Q36784524 | A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology |
Q36801992 | A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes |
Q54290515 | A new method of gene transfer into hematopoietic progenitors using liquid culture with interleukin-3 and interleukin-6. |
Q39958715 | A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses. |
Q54171234 | A new retroviral vector for detecting mutations and chromosomal instability in mammalian cells. |
Q40065940 | A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes |
Q40127173 | A novel retroviruslike family in mouse DNA. |
Q24312874 | A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells |
Q28584741 | A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice |
Q38361147 | A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors |
Q34599447 | A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing |
Q42798292 | A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection |
Q52830964 | A quantitative bioassay for HIV-1 based on trans-activation. |
Q36696345 | A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1 |
Q36884002 | A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth |
Q36795048 | A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina |
Q39578890 | A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences |
Q27626111 | A retroviral RNA kissing complex containing only two G⋅C base pairs |
Q40557379 | A retroviral expression vector containing murine immunoglobulin heavy chain promoter/enhancer |
Q77483210 | A retroviral vector that directs simultaneous expression of alpha and beta T cell receptor genes |
Q33582717 | A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells |
Q36677559 | A retrovirus carrying the K-fgf oncogene induces diffuse meningeal tumors and soft-tissue fibrosarcomas |
Q36784721 | A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues |
Q41367901 | A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line |
Q37005931 | A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation |
Q35896534 | A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions. |
Q41946241 | A role of Ia-associated invariant chains in antigen processing and presentation. |
Q36865708 | A safe packaging line for gene transfer: separating viral genes on two different plasmids |
Q54004846 | A short autocomplementary sequence in the 5' leader region is responsible for dimerization of MoMuLV genomic RNA. |
Q36645054 | A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector |
Q36626426 | A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer |
Q35899379 | A small region of the ecotropic murine leukemia virus (MuLV) gag gene profoundly influences the types of polytropic MuLVs generated in mice. |
Q37251604 | A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes |
Q36958234 | A stem cell-specific silencer in the primer-binding site of a retrovirus |
Q36831014 | A system for studying the selective encapsidation of hepadnavirus RNA. |
Q41709418 | A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters |
Q36881782 | A tagged helper-free Friend virus causes clonal erythroblast immortality by specific proviral integration in the cellular genome |
Q40131826 | A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector. |
Q40390282 | A universal retroviral vector for efficient constitutive expression of exogenous genes |
Q44020560 | A variant Schmidt-Ruppin strain of Rous sarcoma virus with increased affinity for mammalian cells |
Q40556046 | A vector for inducible production of retrovirus |
Q34321338 | A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le |
Q40659924 | Abelson virus transformation of an interleukin 2-dependent antigen-specific T-cell line |
Q36352619 | Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors |
Q41644293 | Accelerated Differentiation in Response to Retinoic Acid After Retrovirally Mediated Gene Transfer of GAP-43 into Mouse Neuroblastoma Cells |
Q36371647 | Accelerated tumor development in interferon-treated B6.C-Hyal-1 a mice. |
Q28117340 | Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling |
Q40818081 | Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro. |
Q36793157 | Activation of cryptic splice sites in murine sarcoma virus-124 mutants |
Q33927736 | Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene |
Q36868495 | Activation of thermosensitive RNA splicing and production of a heat-labile P85gag-mos kinase by the introduction of a specific deletion in murine sarcoma virus-124 DNA |
Q36684169 | Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus |
Q36828870 | Activity of the simian virus 40 early promoter-enhancer in herpes simplex virus type 1 vectors is dependent on its position, the infected cell type, and the presence of Vmw175 |
Q37039973 | Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. |
Q36679535 | Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas |
Q36425596 | Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells |
Q40660263 | Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types |
Q91204548 | Adenovirus vectors in hematopoietic stem cell genome editing |
Q35172114 | Adoptive cellular gene therapy of autoimmune disease |
Q29547239 | Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line |
Q33923877 | Advancements in gene transfer-based therapy for hemophilia A. |
Q40524547 | Advances in cancer gene therapy |
Q60129786 | Advances in recombinant retroviruses for gene delivery |
Q46778204 | Allocation of epiblast cells to germ layer derivatives during mouse gastrulation as studied with a retroviral vector |
Q41533459 | Allocation of mouse cerebellar granule cells derived from embryonic ventricular progenitors--a study using a recombinant retrovirus |
Q34570030 | Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin |
Q38285765 | Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy |
Q40045197 | Alteration of location of dimer linkage sequence in retroviral RNA: little effect on replication or homologous recombination. |
Q35034118 | Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis |
Q42477075 | Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras |
Q70177324 | Altered structure and expression of c-myc in feline T-cell tumours |
Q36947239 | Amphotropic Retrovirus Vector System for Human Cell Gene Transfer |
Q68077548 | Amphotropic murine leukemia retrovirus is not an acute pathogen for primates |
Q36159756 | Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy |
Q40459598 | Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques. |
Q40065013 | An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor |
Q53514290 | An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. |
Q39553970 | An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus |
Q42487416 | An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue |
Q41685343 | An additional dimer linkage structure in Moloney murine leukemia virus RNA. |
Q33571138 | An alternative approach to somatic cell gene therapy |
Q41597214 | An amino-terminal fragment of SV40 T antigen transforms REF52 cells |
Q36796983 | An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor |
Q40527529 | An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV. |
Q33899115 | An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. |
Q45882939 | An ex vivo keratinocyte model for gene therapy of hemophilia B. |
Q41543855 | An experimental model of retrovirus gene therapy for malignant brain tumors |
Q33563598 | An indicator gene to demonstrate intracellular transposition of defective retroviruses |
Q40718366 | An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins |
Q33929573 | An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions |
Q30303886 | An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. |
Q36636798 | An internal deletion enhances the transcriptional activity of a recombinant retrovirus in hematopoietic cells in vivo. |
Q38203066 | Analysing cell lineage with a recombinant retrovirus |
Q36634329 | Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. |
Q41726873 | Analysis of a nontumorigenic embryonal carcinoma cell line |
Q39870267 | Analysis of cis-regulatory elements in the 5' untranslated region of murine leukemia virus controlling protein expression |
Q36529879 | Analysis of early events in acetylcholine receptor assembly |
Q39831901 | Analysis of gene expression during hematopoiesis: present and future applications |
Q40140792 | Analysis of gene expression using Simian Virus 40 vectors |
Q34291639 | Analysis of mammalian cell genetic regulation in situ by using retrovirus-derived "portable exons" carrying the Escherichia coli lacZ gene |
Q36881175 | Analysis of mutant Moloney murine leukemia viruses containing linker insertion mutations in the 3' region of pol. |
Q38767206 | Analysis of the human immunodeficiency virus-1 RNA packageome |
Q57338712 | Analysis of the leukemogenic properties of the bcr-v-abl and GM-CSF genes using a new retroviral vector |
Q36687225 | Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro |
Q28118615 | Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 |
Q54387525 | Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state. |
Q37585001 | Antisense gene silencing: therapy for neurodegenerative disorders? |
Q55517731 | Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model. |
Q40897007 | Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein. |
Q54042034 | Application of LacZ gene fusions to postimplantation development. |
Q36587260 | Application of recombinant DNA technologies to studies on chicken growth hormone |
Q39683721 | Applications of recombinant DNA technology to studies of metabolic regulation |
Q44942700 | Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells |
Q37354432 | Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus |
Q72813269 | Approaches to gene transfer in keratinocytes |
Q42814821 | Assay for expression of methotrexate-resistant dihydrofolate reductase activity in the presence of drug-sensitive enzyme |
Q36651725 | Assembly and composition of intracellular particles formed by Moloney murine leukemia virus |
Q42073571 | Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells |
Q36805988 | Assembly of gag-beta-galactosidase proteins into retrovirus particles |
Q40741342 | Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease |
Q46106956 | Astrogliosis in culture: III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA |
Q48402665 | Authentic and artifactual detection of the E. coli lacZ gene product in the rat brain by histochemical methods |
Q35782312 | Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels |
Q34371516 | Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway |
Q72232450 | Autologous bone marrow transplantation |
Q55242092 | Autonomous growth of lymphoid cells following IL-2 expression from retrovirus vectors containing HIV-1 trans-acting elements. |
Q73215420 | Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor |
Q36639114 | Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs |
Q39194127 | Avian sarcoma viruses |
Q36885381 | Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication |
Q28294137 | Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells |
Q41076577 | Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types |
Q36695175 | Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein |
Q38087759 | Bioinspired peptides as versatile nucleic acid delivery platforms |
Q43434751 | Biological effects of a murine retrovirus carrying an activated N-ras gene of human origin |
Q36951465 | Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors |
Q40835733 | Bone marrow transplant for the haemoglobinopathies: past, present and future |
Q37599502 | Bone marrow transplantation for immunodeficiency and genetic diseases. |
Q40061227 | Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses. |
Q40115785 | Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5'-terminal genomic RNA fragment |
Q45865976 | Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma |
Q40145897 | C/EBPbeta serine 64, a phosphoacceptor site, has a critical role in LPS-induced IL-6 and MCP-1 transcription |
Q84588591 | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells |
Q90066105 | CAR T cells: continuation in a revolution of immunotherapy |
Q38343544 | COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. |
Q24644345 | Capture of a cellular transcriptional unit by a retrovirus: mode of provirus activation in embryonal carcinoma cells |
Q97411761 | Cathepsin B Protease Facilitates Chikungunya Virus Envelope Protein-Mediated Infection via Endocytosis or Macropinocytosis |
Q36764289 | Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature |
Q36233701 | Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis |
Q40952406 | Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation |
Q70046695 | Cell surface receptors for murine leukemia viruses: two assays and their implications |
Q34340632 | Cell transformation and tumor induction by Abelson murine leukemia virus in the absence of helper virus |
Q42808327 | Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain |
Q37157117 | Cells expressing anchorless prion protein are resistant to scrapie infection |
Q52241049 | Cellular and developmental properties of fetal hematopoietic stem cells. |
Q36798019 | Cellular ras gene activity is required for full neoplastic transformation by polyomavirus |
Q33205912 | Change of tropism of SL3-2 murine leukemia virus, using random mutational libraries |
Q53518958 | Changes in in vitro growth behaviour of the mammary epithelial cell line NMuMG caused by the v-fos oncogene. |
Q41690475 | Characterization and comparison of avian and murine helper cell lines for production of replication-defective retroviruses for avian transformation |
Q36791433 | Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein |
Q36892576 | Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants |
Q36892564 | Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biological properties of mutant TK15 and mutant-induced transformants |
Q41470756 | Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences |
Q36885446 | Characterization of a retrovirus shuttle vector capable of either proviral integration or extrachromosomal replication in mouse cells |
Q41743805 | Characterization of a specific form of protein kinase C overproduced by a C3H 10T1/2 cell line |
Q39841033 | Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. |
Q33796418 | Characterization of an internal ribosomal entry segment in the 5' leader of murine leukemia virus env RNA. |
Q42642255 | Characterization of cDNAs of spliced HPV-11 E2 mRNA and other HPV mRNAs recovered via retrovirus-mediated gene transfer |
Q69809293 | Characterization of erythropoietin receptor of murine erythroid cells |
Q28769653 | Characterization of hortulanus endogenous murine leukemia virus, an endogenous provirus that encodes an infectious murine leukemia virus of a novel subgroup |
Q41697078 | Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines |
Q36795724 | Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome |
Q37861192 | Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy |
Q34786043 | Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression |
Q45829446 | Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells |
Q44235096 | Circularization of retroviral genomic RNA and the control of RNA translation, packaging and reverse transcription |
Q40623933 | Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 gene |
Q45852163 | Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. |
Q41207261 | Clinical application of somatic gene therapy in inborn errors of metabolism |
Q35610300 | Clinical trials with retrovirus mediated gene therapy--what have we learned? |
Q52242510 | Clonal and systemic analysis of long-term hematopoiesis in the mouse. |
Q41358959 | Clonal fluctuation within the haematopoietic system of mice reconstituted with retrovirus-infected stem cells |
Q45888930 | Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo |
Q41727860 | Cloning of adenovirus type 12 E1 genes into a retroviral vector and their differential splicing in mouse cells |
Q40254686 | Co-localization of gammaretroviral RNAs at their transcription site favours co-packaging |
Q34634192 | Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication |
Q34669645 | Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication |
Q36553712 | Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice |
Q41245271 | Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo |
Q44022852 | Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells |
Q36669714 | Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning |
Q36872014 | Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. |
Q40600526 | Complementarity-directed RNA dimer-linkage promotes retroviral recombination in vivo |
Q40998383 | Complementation cell lines for viral vectors to be used in gene therapy |
Q34061107 | Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. |
Q35796453 | Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis |
Q35859374 | Conformational analysis of the 5' leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization |
Q31830549 | Conserved transmembrane tyrosine residues of the TCR beta chain are required for TCR expression and function in primary T cells and hybridomas |
Q41498351 | Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines |
Q42806029 | Constitutive interferon expression from retroviral vector |
Q36780266 | Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. |
Q34255941 | Construction and applications of a highly transmissible murine retrovirus shuttle vector |
Q48301018 | Construction and characterization of a packaging cell line for MMTV-based conditional retroviral vectors |
Q69827212 | Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences |
Q41157734 | Construction and characterization of expression systems for the env gene of ts1, a mutant of Moloney murine leukemia virus-TB |
Q42479884 | Construction and hormone regulation of a novel retroviral vector |
Q36752974 | Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance |
Q40680688 | Construction of a Helper Cell Line for Avian Reticuloendotheliosis Virus Cloning Vectors |
Q36835504 | Construction of a defective retrovirus containing the human hypoxanthine phosphoribosyltransferase cDNA and its expression in cultured cells and mouse bone marrow |
Q40559798 | Construction of a retroviral cDNA version of the int-1 mammary oncogene and its expression in vitro |
Q37577400 | Construction of a retrovirus capable of transducing and expressing genes in multipotential embryonic cells |
Q41159282 | Construction of adenoviral and retroviral vectors coexpressing the genes encoding the hepatitis B surface antigen and B7-1 protein |
Q24655892 | Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes |
Q34069096 | Construction of retroviral vectors with improved safety, gene expression, and versatility. |
Q45835763 | Control of Rous sarcoma virus RNA translation and packaging by the 5' and 3' untranslated sequences |
Q30176883 | Controlled overexpression of selected domains of the P85 subunit of phosphatidylinositol 3-kinase reverts v-Ha-Ras transformation. |
Q42606945 | Correlation between tumorigenicity and expression levels or splicing patterns of transcripts of the human papillomavirus type 16 E6 gene |
Q37498960 | Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen |
Q43169551 | Cre-loxP-mediated DNA flip-flop in mammalian cells leading to alternate expression of retrovirally transduced genes |
Q28066817 | Cross- and Co-Packaging of Retroviral RNAs and Their Consequences |
Q45743710 | Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein |
Q39149692 | Current perspectives in the biology of mouse mammary tumour virus |
Q42829762 | Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA-adduct formation of aromatic amine carcinogens in NIH 3T3 cells |
Q33836499 | DNA as therapeutics; an update |
Q34241750 | DNA damage signals through differentially modified E2F1 molecules to induce apoptosis |
Q36488623 | DNA-mediated genetic transformation of mouse embryos and bone marrow--a review |
Q68183881 | Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA |
Q40107270 | Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo |
Q34320638 | Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. |
Q36839982 | Definition of regions in human c-myc that are involved in transformation and nuclear localization |
Q72965018 | Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas |
Q42806402 | Deletion of the beta-turn/alpha-helix motif at the exon 2/3 boundary of human c-Myc leads to the loss of its immortalizing function |
Q35831703 | Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia. |
Q36882543 | Design of retrovirus vectors for transfer and expression of the human beta-globin gene. |
Q33648331 | Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans |
Q33932054 | Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis |
Q45835632 | Determinants of Abelson murine leukemia virus pathogenesis |
Q40607690 | Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions |
Q40062655 | Determinants of retrovirus gene expression in embryonal carcinoma cells |
Q36623632 | Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells. |
Q36828208 | Development and characterization of an Fv-1-sensitive retrovirus-packaging system: single-hit titration kinetics observed in restrictive cells. |
Q41074115 | Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer |
Q85995613 | Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine |
Q36811215 | Development of a retroviral vector for inducible expression of transforming growth factor beta 1. |
Q40797068 | Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors |
Q54438081 | Development of an amphotropic, high-titer retrovirus vector expressing the dihydrofolate reductase gene and conferring methotrexate resistance. |
Q40129979 | Development of avian sarcoma and leukosis virus-based vector-packaging cell lines |
Q37149183 | Development of gene therapy for blood disorders |
Q38290277 | Development of gene transfer technology |
Q41523329 | Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells |
Q40944251 | Development of retroviral vectors as safe, targeted gene delivery systems |
Q52261166 | Developmental potential and dynamic behavior of hematopoietic stem cells. |
Q52255081 | Developmental stage specificity of the lymphoid V(D)J recombination activity. |
Q36632478 | Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. |
Q40117741 | Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. |
Q45757448 | Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice |
Q34191729 | Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells |
Q40265750 | Differential roles of C/EBP beta regulatory domains in specifying MCP-1 and IL-6 transcription |
Q52085152 | Differentiation of PC12 cells with v-src: comparison with nerve growth factor. |
Q35616718 | Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity |
Q41257165 | Dimerization of retroviral genomic RNAs: structural and functional implications |
Q36455818 | Direct gene therapy for repair of the spinal cord |
Q53435589 | Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6. |
Q41582641 | Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line |
Q40470208 | Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts. |
Q41722866 | Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping |
Q41683269 | Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene |
Q40755894 | Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins |
Q34259037 | Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. |
Q36760642 | Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures |
Q36816122 | Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo |
Q45858383 | Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. |
Q30474181 | Effect of hydrophobic mutations in the H2-H3 subdomain of prion protein on stability and conversion in vitro and in vivo. |
Q36887920 | Effect of internal viral sequences on the utility of retroviral vectors |
Q36486121 | Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P. |
Q36826993 | Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction |
Q42326908 | Effects of an internal transcription unit and its orientation on retrovirus titre and expression |
Q46659741 | Effects of choline and quiescence on Drosophila choline acetyltransferase expression and acetylcholine production by transduced rat fibroblasts |
Q34073981 | Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells |
Q38304776 | Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. |
Q34592991 | Efficient and stable expression of recombinant fibronectin polypeptides |
Q39604725 | Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells |
Q41673873 | Efficient gene transfer and expression in primary B lymphocytes |
Q41711534 | Efficient gene transfer in live mice using a unique retroviral packaging line |
Q37490464 | Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus |
Q37541994 | Efficient insertion of genes into the mouse germ line via retroviral vectors |
Q35605519 | Efficient recovery and sequencing of mutant genes from mammalian chromosomal DNA |
Q40588218 | Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions |
Q40518517 | Efficient replication, integration, and packaging of retroviral vectors with modified long terminal repeats containing the packaging signal |
Q54346600 | Efficient retroviral transfer of a mouse c-myc construct into HL60. |
Q36782879 | Elevated expression of pp60c-src alters a selective morphogenetic property of epithelial cells in vitro without a mitogenic effect |
Q33909953 | Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells |
Q35289952 | Employment of fibroblasts for gene transfer: applications for grafting into the central nervous system |
Q36737272 | Endocytosis via coated pits mediated by glycoprotein receptor in which the cytoplasmic tail is replaced by unrelated sequences |
Q41675906 | Enhanced growth characteristics of hybridoma cells infected with myc- and ras-containing retroviruses |
Q40455802 | Enhanced insulin secretion from engineered 3T3-L1 preadipocytes by induction of cellular differentiation. |
Q33897429 | Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA |
Q34373796 | Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells |
Q42810400 | Episomal vectors rapidly and stably produce high-titer recombinant retrovirus |
Q43583241 | Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene |
Q35755192 | ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer |
Q40729129 | ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation. |
Q40044286 | Erythropoietin receptor (EpoR)-dependent mitogenicity of spleen focus-forming virus correlates with viral pathogenicity and processing of env protein but not with formation of gp52-EpoR complexes in the endoplasmic reticulum. |
Q45883740 | Escherichia coli DNA contamination in AmpliTaq Gold polymerase interferes with TaqMan analysis of lacZ. |
Q41534215 | Establishment and neurite outgrowth properties of neonatal and adult rat olfactory bulb glial cell lines. |
Q42829154 | Establishment of Schwann cell lines by oncogene transfer |
Q41630798 | Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus |
Q43711622 | Establishment of megakaryoblastic cell lines by coinfection of Abelson murine leukemia virus and recombinant SV40-retrovirus. |
Q36425970 | Eucaryotic chromosome transfer: production of a murine-specific cosmid library from a neor-linked fragment of murine chromosome 17. |
Q37561804 | Eukaryotic chromosome transfer: linkage of the murine major histocompatibility complex to an inserted dominant selectable marker |
Q41581372 | Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies |
Q37127639 | Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade |
Q27486633 | Evidence for specificity in the encapsidation of Sindbis virus RNAs |
Q33573875 | Evidence that retroviral transduction is mediated by DNA not by RNA. |
Q41741318 | Evidence that the level of the p55 component of the interleukin (IL) 2 receptor can control IL 2 responsiveness in a murine IL 3-dependent cell |
Q36887904 | Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region |
Q24321231 | Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein |
Q39874520 | Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process |
Q42832459 | Excision of an integrated provirus by the action of FLP recombinase |
Q68167505 | Exogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: grafting in an animal model of Parkinson's disease |
Q33901213 | Exon trapping: a genetic screen to identify candidate transcribed sequences in cloned mammalian genomic DNA. |
Q35526805 | Experimental and clinical applications of molecular cell biology in nutrition and metabolism |
Q38261224 | Expression and analysis of the polymeric immunoglobulin receptor in Madin-Darby canine kidney cells using retroviral vectors |
Q43842081 | Expression and functional analysis of G protein alpha subunits in S49 lymphoma cells |
Q36923439 | Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors |
Q54441070 | Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. |
Q69876571 | Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity |
Q70365424 | Expression of a retrovirus encoding human HPRT in mice |
Q40064802 | Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles. |
Q69249459 | Expression of an exogenous growth hormone gene by transplantable human epidermal cells |
Q36428262 | Expression of functional human EGF receptor on murine bone marrow cells |
Q45247574 | Expression of functional human interleukin-2 receptors in murine interleukin-3-dependent cells |
Q44136225 | Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer |
Q36849892 | Expression of human adenosine deaminase in murine hematopoietic cells |
Q37676406 | Expression of human adenosine deaminase using a transmissable murine retrovirus vector system |
Q33619761 | Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses |
Q42810847 | Expression of human argininosuccinate synthetase after retroviral-mediated gene transfer |
Q41858311 | Expression of human argininosuccinate synthetase in murine hematopoietic cells in vivo |
Q34611661 | Expression of human class II major histocompatibility complex antigens using retrovirus vectors |
Q37594306 | Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B |
Q41530887 | Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. |
Q37125290 | Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity |
Q42816254 | Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer |
Q54436699 | Expression of murine ADA cDNA in bacterial and mammalian cells. |
Q41536608 | Expression of p210 bcr/abl increases hematopoietic progenitor cell radiosensitivity. |
Q41619396 | Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors |
Q41670691 | Expression of porcine pro-opiomelanocortin in mouse neuroblastoma (Neuro2A) cells: targeting of the foreign neuropeptide to dense-core vesicles |
Q28583975 | Expression of recombinant myelin-associated glycoprotein in primary Schwann cells promotes the initial investment of axons by myelinating Schwann cells |
Q33928812 | Expression of retroviral vectors in transgenic mice obtained by embryo infection |
Q41545350 | Expression of the E.coli 3-methyladenine DNA glycosylase I gene in mammalian cells reduces the toxic and mutagenic effects of methylating agents |
Q36808211 | Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor |
Q34626255 | Expression of the Saccharomyces cerevisiae glycoprotein invertase in mouse fibroblasts: glycosylation, secretion, and enzymatic activity |
Q36787086 | Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells. |
Q42800350 | Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. |
Q54227846 | Expression of the non-structural proteins of parvovirus MVMp from recombinant retroviruses: predominant role of the parvoviral NS-1 product in host cell disturbance. |
Q36447654 | Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene |
Q36361923 | Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis |
Q41754082 | Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1. |
Q77576573 | Expression vectors and delivery systems |
Q41448240 | Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA. |
Q38339423 | Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors |
Q36532847 | Extracellular synaptic factors induce clustering of acetylcholine receptors stably expressed in fibroblasts |
Q45846747 | Factors affecting long-term stability of Moloney murine leukemia virus-based vectors |
Q45831591 | Factors involved in production of helper virus-free retrovirus vectors. |
Q36799015 | Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells |
Q34294780 | Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor |
Q48241475 | Fate and behavior of genetically labeled cerebellar cells after transplantation into mouse cerebellum |
Q36220753 | Fibroblasts transfected with Torpedo acetylcholine receptor beta-, gamma-, and delta-subunit cDNAs express functional receptors when infected with a retroviral alpha recombinant |
Q41649141 | Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence |
Q41580966 | Flow cytometric titration of retroviral expression vectors: comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels |
Q33567244 | Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ |
Q35196137 | Foamy virus vectors. |
Q45746032 | Forced recombination of psi-modified murine leukaemia virus-based vectors with murine leukaemia-like and VL30 murine endogenous retroviruses |
Q41693626 | Formation of Noninfectious HIV-1 Virus Particles Lacking a Full-Length Envelope Protein |
Q36827701 | Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus |
Q48366755 | Forty years with homologous recombination |
Q36944466 | Frequent hereditable shutdown of murine retrovirus gene expression in murine cell lines |
Q34865747 | Functional analysis and nucleotide sequence of the promoter region of the murine hck gene |
Q34333382 | Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells |
Q53520259 | Functional dissociation of transforming genes of human papillomavirus type 16. |
Q70464379 | Functional expression of a cloned I-A beta k gene in B-lymphoma cells |
Q41732514 | Functional expression of dihydropyridine-insensitive calcium channels during PC12 cell differentiation by nerve growth factor (NGF), oncogenic ras, or src tyrosine kinase |
Q36214583 | Functional expression of the polymeric immunoglobulin receptor from cloned cDNA in fibroblasts |
Q39605206 | Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus |
Q58327019 | Gene Transfer Into the Germ Line of Mice and Into Embryonal Carcinoma Stem Cells |
Q38289974 | Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival |
Q39984515 | Gene delivery by retroviruses |
Q41716747 | Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line |
Q70111454 | Gene expression in mice after high efficiency retroviral-mediated gene transfer |
Q60912540 | Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer's disease mouse model |
Q64973001 | Gene isolation by retroviral tagging. |
Q43456650 | Gene overlap results in a viral protein having an RNA binding domain and a major coat protein domain |
Q67528501 | Gene therapy |
Q70935363 | Gene therapy |
Q71843696 | Gene therapy |
Q47554885 | Gene therapy comes of age. |
Q60360924 | Gene therapy for Parkinson's disease |
Q64382253 | Gene therapy for Parkinson's disease |
Q38694710 | Gene therapy for genetic diseases |
Q35236239 | Gene therapy for human inherited disorders: techniques and status |
Q45856156 | Gene therapy for inherited neurological disorders: towards therapeutic intervention in the Lesch-Nyhan syndrome. |
Q37610257 | Gene therapy for malignant brain tumors |
Q38364511 | Gene therapy for primary immunodeficiencies. |
Q35652189 | Gene therapy for vascular diseases |
Q45191990 | Gene therapy in the CNS: intracerebral grafting of genetically modified cells. |
Q33217113 | Gene therapy in the cornea |
Q41625113 | Gene therapy of Duchenne muscular dystrophy. |
Q41297688 | Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir |
Q45876121 | Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells |
Q38753904 | Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials |
Q40530271 | Gene therapy vectors as drug delivery systems |
Q34931179 | Gene therapy with viral vectors |
Q38853561 | Gene therapy: Myth or reality? |
Q37942103 | Gene therapy: current status and future directions |
Q26772109 | Gene therapy: progress and predictions |
Q34101058 | Gene therapy: promises and problems. |
Q36161193 | Gene therapy: twenty-first century medicine |
Q35647626 | Gene transfer and genome-wide insertional mutagenesis by retroviral transduction in fish stem cells |
Q37737788 | Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies. |
Q58149730 | Gene transfer into bovine cells and embryos using replication‐defective retroviral vectors encapsidated with xenotropic murine leukemia virus envelopes |
Q44221281 | Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors |
Q40607279 | Gene transfer into hematopoietic progenitor and stem cells: progress and problems. |
Q35261136 | Gene transfer into hematopoietic stem cells: prospects for human gene therapy |
Q38681713 | Gene transfer into hemopoietic stem cells using retroviral vectors |
Q24647777 | Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector |
Q68877418 | Gene transfer into humans: a first step |
Q38037038 | Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells |
Q38646175 | Gene transfer into primates and prospects for gene therapy in humans |
Q44441663 | Gene transfer into rat airway epithelial cells using retroviral vectors |
Q39581687 | Gene transfer into the nervous system |
Q45775033 | Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors |
Q71346908 | Gene transfer on its long path to therapeutic application |
Q35887352 | Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line |
Q38686576 | Gene transfer. A potential approach to gene therapy for sickle cell disease |
Q59280523 | Gene-search viruses and FACS-Gal permit the detection, isolation, and characterization of mammalian cells with in situ fusions between cellular genes and Escherichia coli lacZ |
Q34094064 | Generating mice with targeted mutations |
Q91942885 | Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells |
Q36780473 | Generation of a helper cell line for packaging avian leukosis virus-based vectors. |
Q40069386 | Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media |
Q45847956 | Generation of competent virus in the REV helper cell line C3. |
Q36886039 | Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene |
Q40718975 | Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors |
Q34066344 | Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery |
Q39830015 | Genetic complexity and expression of human class II histocompatibility antigens |
Q36744055 | Genetic definition of ras effector elements |
Q33655095 | Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB. |
Q68724967 | Genetic engineering of animals |
Q64382339 | Genetic immunotherapy for cancer |
Q59599919 | Genetic manipulation of hematopoietic stem cells with retrovirus vectors |
Q53483163 | Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. |
Q33693779 | Genetic regulatory elements introduced into neural stem and progenitor cell populations |
Q36792561 | Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo |
Q40905745 | Genetic therapy. Past, present, and future |
Q37610792 | Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease |
Q54249393 | Genomic rearrangements of retroviral vectors carrying two genes in F9 EC cells |
Q36453658 | Genotoxicity of retroviral integration in hematopoietic cells. |
Q36759140 | Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. |
Q34189858 | Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector |
Q30468679 | Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion |
Q41464482 | Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization |
Q40511076 | Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections. |
Q41757700 | Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene |
Q34320662 | Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease |
Q43543978 | Grafting genetically modified cells into the rat brain: characteristics of E. coli beta-galactosidase as a reporter gene |
Q37610789 | Grafting genetically modified cells to the brain: conceptual and technical issues |
Q39694407 | Grafting genetically modified cells to the brain: possibilities for the future |
Q43839045 | Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression |
Q72085554 | Granulocyte colony‐stimulating factor treatment of mice modulates differently the sensitivity of blood and bone marrow hematopoietic progenitors to retroviral vector infection |
Q41953353 | Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo |
Q67506342 | Growth factor-like effects mediated by muscarinic receptors in PC12M1 cells |
Q41388906 | Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. |
Q33862904 | Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells |
Q36890377 | H-2Ld antigen encoded by a recombinant retrovirus genome is expressed on the surface of infected cells |
Q36641150 | HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice |
Q34443134 | HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. |
Q24301505 | HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor |
Q45111676 | HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology |
Q34614346 | Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells |
Q36362319 | Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages |
Q36876655 | Heat shock protein hsp70 protects cells from thermal stress even after deletion of its ATP-binding domain |
Q36231835 | Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer |
Q41450695 | Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders |
Q35870965 | Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. |
Q36965464 | Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions |
Q45889093 | Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery |
Q43997265 | Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages |
Q40852248 | Herpesviruses: expression of genes in postmitotic brain cells |
Q54401908 | High efficiency gene transfer and expression in normal murine B lymphocytes. |
Q40823437 | High expression of human 15-lipoxygenase induces NF-kappaB-mediated expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and T-cell adhesion on human endothelial cells |
Q36551618 | High titers of retrovirus (vesicular stomatitis virus) pseudotypes, at last |
Q34611394 | High-affinity interleukin 2 binding by an oncogenic hybrid interleukin 2-epidermal growth factor receptor molecule |
Q68780717 | High-efficiency gene transfer into cells |
Q37572832 | High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range |
Q45885718 | High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors |
Q54375928 | Highly efficient action of autocrine mouse interferon-gamma expressed via a retroviral vector. |
Q33868950 | Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia |
Q33932573 | Homologous recombination of copackaged retrovirus RNAs during reverse transcription |
Q70127247 | Homology among oncogenes |
Q26767304 | Host RNA Packaging by Retroviruses: A Newly Synthesized Story |
Q30195331 | Host range mutants of v-src: alterations in kinase activity and substrate interactions |
Q36215749 | How retroviruses select their genomes |
Q42806237 | Human beta-globin gene expression after gene transfer using retroviral vectors |
Q36799805 | Human cells infected with retrovirus vectors acquire an endogenous murine provirus |
Q70143048 | Human gene therapy |
Q36309600 | Human gene therapy: present and future |
Q40663428 | Human genetic therapy |
Q41376860 | Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element |
Q41283198 | Human somatic cell gene therapy |
Q41142780 | Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells |
Q41705456 | IL-6 Production by Retrovirus Packaging Cells and Cultured Bone Marrow Cells |
Q36698033 | Identification and characterization of a coronavirus packaging signal |
Q36830945 | Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. |
Q67493322 | Identification of a generalised packaging sequence for D-type retroviruses and generation of a D-type retroviral vector |
Q42387383 | Identification of a high affinity nucleocapsid protein binding element from the bovine leukemia virus genome |
Q45734713 | Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition |
Q36634317 | Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus |
Q24645417 | Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions |
Q40129310 | Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions |
Q36829664 | Identification of cellular promoters by using a retrovirus promoter trap |
Q88917043 | Identification of conserved, primary sequence motifs that direct retrovirus RNA fate |
Q33642167 | Identification of directly infected cells in the bone marrow of neonatal moloney murine leukemia virus-infected mice by use of a moloney murine leukemia virus-based vector. |
Q36923563 | Identification of protein products encoded by the proto-oncogene int-1 |
Q38347886 | Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. |
Q41446266 | Immortalization of immature and mature mouse astrocytes with SV40 T antigen. |
Q33572128 | Immortalization of mouse neural precursor cells by the c-myc oncogene |
Q69119104 | Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus |
Q41334777 | Immunoglobulin heavy chain switch region recombination within a retroviral vector in murine pre-B cells |
Q37597644 | Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer |
Q41022147 | Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency |
Q48159155 | Implantation of genetically engineered cells to the brain. |
Q41064189 | Improvement of retroviral packaging cell lines by introducing the polyomavirus early region |
Q41490944 | In vitro and in vivo characterisation of glial cells immortalised with a temperature sensitive SV40 T antigen-containing retrovirus. |
Q53524994 | In vitro and in vivo regulation of liver epithelial cells carrying a metallothionein-rasT24 fusion gene. |
Q33653475 | In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. |
Q36867600 | In vitro synthesis of infectious retroviral RNA |
Q34347155 | In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome |
Q33670561 | In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin |
Q45984137 | In vivo production and release of acetylcholine from primary fibroblasts genetically modified to express choline acetyltransferase. |
Q39581188 | In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal |
Q27486825 | Increase of retroviral infection in vitro by the binding of antiretroviral antibodies |
Q40671178 | Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector |
Q34631459 | Increased radiation-induced transformation in C3H/10T1/2 cells after transfer of an exogenous c-myc gene |
Q33634411 | Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene |
Q41525843 | Increased viral titer through concentration of viral harvests from retroviral packaging lines |
Q28345681 | Independent influence of strain difference and mi transcription factor on the expression of mouse mast cell chymases |
Q36852773 | Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression |
Q36842787 | Individual mouse VL30 elements transferred to rat cells by viral pseudotypes retain their responsiveness to activators of protein kinase C. |
Q41703408 | Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras |
Q24652685 | Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae |
Q41141469 | Induction of murine CD5 expression by v-H-ras |
Q37601224 | Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc |
Q43812637 | Induction of plasmacytomas that secrete monoclonal anti-peptide antibodies by retroviral transformation |
Q45836665 | Induction of the autonomous stage of transformation in erythroid cells infected with SFFV: helper virus is not required |
Q37535996 | Induction of the early stages of Friend erythroleukemia with helper-free Friend spleen focus-forming virus |
Q37656060 | Induction of transcription from the long terminal repeat of Moloney murine sarcoma provirus by UV-irradiation, x-irradiation, and phorbol ester |
Q54357759 | Infection of bovine cells of embryonic origin by amphotropic retroviral vectors. |
Q37689072 | Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase |
Q41724335 | Infection with Murine Retrovirus Confers Resistance to the Neurotoxin 1-Methyl-4-Phenylpyridinium Ion in PC12 Cells |
Q45085478 | Infectious and Selectable Retrovirus Containing an Inducible Rat Growth Hormone Minigene |
Q30430249 | Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. |
Q88772902 | Influence of gag and RRE Sequences on HIV-1 RNA Packaging Signal Structure and Function |
Q43842559 | Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac |
Q41399114 | Influence of tyrosine residues Y705 and Y807 on the transforming potency of the v-fms oncogene product of feline sarcoma virus |
Q28237847 | Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s) |
Q37511861 | Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences |
Q40615471 | Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression |
Q40100354 | Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA. |
Q38333070 | Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression |
Q40199297 | Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs |
Q41603934 | Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. |
Q42812739 | Inhibition of the Moloney murine leukemia virus cycle at a post reverse transcriptional step by the netropsin-intercalating hybrid molecule netropsin-oxazolopyridocarbazole |
Q37540402 | Insertion of a bacterial gene into the mouse germ line using an infectious retrovirus vector. |
Q39702035 | Insertion of dominant selectable markers into the human genome |
Q44387670 | Insertion of hypoxanthine phosphoribosyltransferase cDNA into human bone marrow cells by a retrovirus. |
Q37536018 | Insertion of the bacterial gpt gene into the germ line of mice by retroviral infection |
Q41455365 | Insertion of the human cytomegalovirus enhancer into a myeloproliferative sarcoma virus long terminal repeat creates a high-expression retroviral vector |
Q40988290 | Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression |
Q44140193 | Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells |
Q44914199 | Insertional mutagenesis to isolate genes |
Q28083335 | Insights into the nuclear export of murine leukemia virus intron-containing RNA |
Q36872242 | Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor |
Q41150442 | Interacting residues in the extracellular region of the common beta subunit of the human granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptors involved in constitutive activation. |
Q40959601 | Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour |
Q54348374 | Interferon-mediated inhibition of retroviral infection: use of a defective retrovirus carrying a drug-resistance gene. |
Q36362418 | Interleukin 2 activates extracellular signal-regulated protein kinase 2. |
Q36231901 | Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents |
Q24339580 | Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's |
Q41486062 | Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. |
Q40677768 | Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine |
Q44534068 | Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. |
Q45129684 | Intracerebral grafting of genetically modified cells acting as biological pumps |
Q36388622 | Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130 |
Q78128999 | Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus |
Q63965567 | Introduction and Expression of the Interleukin 2 Receptor (Tac) Gene in Hematopoietic Stem Cells with Retrovirus Vectors |
Q37577456 | Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector |
Q54134810 | Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. |
Q35586255 | Introduction of genes into preimplantation mouse embryos by use of a defective recombinant retrovirus |
Q52273129 | Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse |
Q53747308 | Introduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle system. |
Q35063101 | Invasive drug delivery. |
Q41654477 | Investigation of a possible role of the amino-terminal pro-region of proopiomelanocortin in its processing and targeting to secretory granules |
Q41650686 | Investigation of the mutagenic specificity of X-rays using a retroviral shuttle vector in CHO cells |
Q28287538 | Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways |
Q42806933 | Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice |
Q35763983 | Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3 |
Q36530944 | Isoform-specific subcellular targeting of glucose transporters in mouse fibroblasts |
Q42809755 | Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts |
Q36883617 | Isolation and characterization of NIH 3T3 cells expressing polyomavirus small T antigen. |
Q41692064 | Isolation and characterization of irradiation fusion hybrids from mouse chromosome 1 for mapping Rmc-1, a gene encoding a cellular receptor for MCF class murine retroviruses |
Q36949872 | Isolation of Large T Antigen-Producing Mouse Cell Lines Capable of Supporting Replication of Polyomavirus-Plasmid Recombinants |
Q36855313 | Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. |
Q41685936 | Isolation of cellular revertants from a rat cell line transformed by the E6 and E7 genes of human papillomavirus type 16 |
Q36797188 | Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin |
Q64516813 | Joining of VK to JK gene segments in a retroviral vector introduced into lymphoid cells |
Q41638615 | Juxtaglomerular cells cultured on a reconstituted basement membrane |
Q42939025 | Kirsten murine sarcoma virus abolishes interferon gamma-induced class II but not class I major histocompatibility antigen expression in a murine fibroblast line |
Q34467839 | LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives |
Q36918344 | Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line |
Q41217979 | Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. |
Q40292793 | Latent murine leukemia virus infection characterized by the release of non-infectious virions |
Q52726162 | Lentiviral Transduction of Rat Schwann Cells and Dorsal Root Ganglia Neurons for In Vitro Myelination Studies. |
Q64057516 | Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma |
Q45324668 | Lentiviral vectors and adeno-associated virus vectors: useful tools for gene transfer in pain research |
Q38147100 | Lentiviral vectors for cancer immunotherapy and clinical applications |
Q36760023 | Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. |
Q24629462 | Lentiviral vectors in gene therapy: their current status and future potential |
Q33290074 | Library selection and directed evolution approaches to engineering targeted viral vectors |
Q34496697 | Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines. |
Q38135674 | Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status |
Q34585324 | Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer |
Q74603312 | Lineage analysis using retroviral vectors |
Q41619715 | Lineage analysis using retroviral vectors. |
Q36754856 | Lineage analysis using retrovirus vectors |
Q41387628 | Lineage analysis using retrovirus vectors |
Q73110159 | Lineage analysis with retroviral vectors |
Q41531133 | Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system |
Q24634002 | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure |
Q68104570 | Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice |
Q36710306 | Localization of sequences required in cis for yeast Ty1 element transposition near the long terminal repeats: analysis of mini-Ty1 elements |
Q34578841 | Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice |
Q33926209 | Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells |
Q41187067 | Long-term expression of gene introduction into normal human T-lymphocytes by retroviral-mediated gene transfer |
Q34319569 | Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells |
Q36822821 | Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells |
Q36826874 | Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv |
Q33638488 | Low-affinity placenta-derived receptors for human granulocyte-macrophage colony-stimulating factor can deliver a proliferative signal to murine hemopoietic cells |
Q40456084 | MDR gene transfer into live mice. |
Q37481899 | MTrasT24, a metallothionein-ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer |
Q36710324 | Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes |
Q69074595 | Malignant progression of papilloma-derived keratinocytes: differential effects of the ras, neu, and p53 oncogenes |
Q53543492 | Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector. |
Q36883310 | Mammalian cell transformation by a murine retrovirus vector containing the avian erythroblastosis virus erbB gene |
Q45836967 | Mammalian expression-and-transmission vector derived from Akv murine leukemia virus |
Q39750602 | Mammalian gene transfer and gene expression |
Q57271413 | Manipulating DNA: from Cloning to Knockouts |
Q36652049 | Maturation of dimeric viral RNA of Moloney murine leukemia virus. |
Q41635111 | Measurement of hygromycin B phosphotransferase activity in crude mammalian cell extracts by a simple dot-blot assay |
Q36753246 | Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer |
Q37904362 | Micromanipulation of embryos and germ cells: an approach to gene therapy? |
Q28295218 | Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localization |
Q54311159 | MoMuLV-derived self-inactivating retroviral vectors possessing multiple cloning sites and expressing the resistance to either G418 or hygromycin B. |
Q36762877 | Mock retroviral infection alters the developmental potential of murine bone marrow stem cells |
Q38352848 | Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter. |
Q34593412 | Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer |
Q45730219 | Modulation of homo- and heterodimerization of Harvey sarcoma virus RNA by GACG tetraloops and point mutations in palindromic sequences |
Q36560927 | Modulation of thermal induction of hsp70 expression by Ku autoantigen or its individual subunits |
Q40832214 | Molecular approaches to cancer therapy. |
Q45201906 | Molecular basis of alpha 1-antitrypsin deficiency and its potential therapy by gene transfer |
Q36586876 | Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences |
Q39736121 | Molecular genetics and potential gene therapy |
Q46638492 | Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). |
Q39341963 | Moloney murine leukemia virus genomic RNA packaged in the absence of a full complement of wild type nucleocapsid protein |
Q33654203 | Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice. |
Q33785012 | Monitoring retroviral RNA dimerization in vivo via hammerhead ribozyme cleavage. |
Q41722615 | Monochromosomal mouse microcell hybrids containing inserted selectable neo genes |
Q41745011 | Monochromosomal rodent-human hybrids from microcell fusion of human lymphoblastoid cells containing an inserted dominant selectable marker |
Q45835860 | Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cells |
Q69735738 | Multi-copy introduction and high-level expression of interleukin-3 genes by retroviral vector superinfection |
Q37582808 | Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection |
Q41809902 | Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene |
Q37727542 | Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant |
Q34467477 | Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform |
Q41112430 | Multiple transduction as a means of preserving ganciclovir chemosensitivity in sarcoma cells carrying retrovirally transduced herpes thymidine kinase genes |
Q59355961 | Multiple, Switchable Protein:RNA Interactions Regulate Human Immunodeficiency Virus Type 1 Assembly |
Q53516187 | Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. |
Q42814584 | Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity |
Q40818078 | Murine myeloid cell lines derived by in vitro infection with recombinant c-myb retroviruses express myb from rearranged vector proviruses |
Q36657459 | Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation |
Q45854041 | Murine retroviral vectors expressing the tax1 gene of human T-cell leukemia virus type 1. |
Q42196238 | Mus spicilegus endogenous retrovirus HEMV uses murine sodium-dependent myo-inositol transporter 1 as a receptor. |
Q37198429 | Musings on genome medicine: gene therapy |
Q39509704 | Mutants of murine leukemia viruses and retroviral replication |
Q38314018 | Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication |
Q40176579 | Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release |
Q40107061 | Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein |
Q36634241 | Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. |
Q41044335 | Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus |
Q35828610 | Mutational analysis of the murine AIDS-defective viral genome reveals a high reversion rate in vivo and a requirement for an intact Pr60gag protein for efficient induction of disease |
Q33880314 | Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization |
Q36804927 | Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus |
Q39588854 | Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. |
Q33681365 | Myc-induced cyclin D2 genomic instability in murine B cell neoplasms. |
Q33330955 | Myeloproliferative disorder and leukaemia in mice induced by different classes of constitutive mutants of the human IL-3/IL-5/GM-CSF receptor common beta subunit |
Q36634970 | Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells |
Q72039728 | N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6 |
Q44904852 | NBP, a protein that specifically binds an enhancer of immunoglobulin gene rearrangement: purification and characterization |
Q34283905 | NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression |
Q100424291 | NMR Studies of Retroviral Genome Packaging |
Q40671312 | Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src |
Q41206626 | Negative autoregulation of c-myc transcription |
Q35891618 | Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. |
Q36375906 | Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. |
Q40040268 | Negative regulation of the 5' long terminal repeat (LTR) by the 3' LTR in the murine proviral genome. |
Q51192930 | Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirus-associated oncogenes. |
Q36782472 | Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck) |
Q41338744 | Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras. |
Q40609652 | New Structure Sheds Light on Selective HIV-1 Genomic RNA Packaging |
Q36838229 | Nonmitogenic morphoregulatory action of pp60v-src on multicellular epithelial structures |
Q40678630 | Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line |
Q34092811 | Nonrandom packaging of host RNAs in moloney murine leukemia virus |
Q42830421 | Normal human melanocytes that express a bFGF transgene still require exogenous bFGF for growth in vitro |
Q36690303 | Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus |
Q41717906 | Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals |
Q34302330 | Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation |
Q40530367 | Nucleotide sequence of mouse virus-like (VL30) retrotransposon BVL-1. |
Q40390840 | On the conformational stability of the smallest RNA kissing complexes maintained through two G·C base pairs |
Q39716258 | On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines |
Q69575348 | Oncogene activation and surface markers in mouse lymphomas induced by radiation and nitrosomethylurea |
Q36752903 | Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl |
Q39532738 | Oncogenes in transgenic mice |
Q42289065 | Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion |
Q34561988 | Opportunities for the use of lentiviral vectors in human gene therapy |
Q33782598 | Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family. |
Q33634507 | Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes |
Q38786382 | Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. |
Q42831651 | Overexpression of protein kinase C alpha-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor |
Q41448332 | Overexpression of protein kinase C beta I in a murine keratinocyte cell line produces effects on cellular growth, morphology and differentiation |
Q36723752 | Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression |
Q28571162 | Overproduction of protein kinase C causes disordered growth control in rat fibroblasts |
Q40014482 | Overview of the retrovirus transduction system |
Q40689692 | PA 317 retrovirus packaging cells |
Q36649979 | Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region. |
Q40067097 | Packaging system for rapid production of murine leukemia virus vectors with variable tropism |
Q42799687 | Partial isolation from intact cells of a cell surface-exposed lysophosphatidylinositol-phospholipase C. |
Q35996377 | Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus |
Q39842422 | Perspectives for gene therapy: inserting new genetic information into mammalian cells by physical techniques and viral vectors |
Q69731655 | Perspectives on UV light mutagenesis: investigation of the CHO aprt gene carried on a retroviral shuttle vector |
Q41760401 | Phenotypic effects of overexpression of PKC beta 1 in rat liver epithelial cells |
Q41627940 | Photodynamic inactivation of retroviruses by phthalocyanines: the effects of sulphonation, metal ligand and fluoride |
Q36811075 | Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production |
Q36827892 | Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor |
Q36690316 | Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein |
Q33669533 | Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence |
Q37624867 | Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity |
Q46151972 | Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription |
Q44429876 | Portable encapsidation signal of the L-A double-stranded RNA virus of S. cerevisiae |
Q36827825 | Positive Selectable Markers for Use with Mammalian Cells in Culture |
Q33829038 | Positive genetic selection for gene disruption in mammalian cells by homologous recombination |
Q36753045 | Posttranscriptional regulation of cellular gene expression by the c-myc oncogene |
Q37405342 | Potentiation of growth factor activity by exogenous c-myc expression. |
Q41028945 | Preclinical characterization of an anti-tat ribozyme for therapeutic application |
Q41017656 | Preparation of brain-derived neurotrophic factor- and neurotrophin-3-secreting Schwann cells by infection with a retroviral vector |
Q68763779 | Preproparathyroid hormone. A model for analyzing the secretory pathway |
Q36620087 | Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains |
Q40300058 | Prion infection influences murine endogenous retrovirus expression in neuronal cells |
Q27485991 | Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study |
Q34597261 | Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector |
Q41743293 | Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV |
Q37263723 | Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors |
Q39989759 | Production of retroviral vectors |
Q42813419 | Production of spliced DNA copies of the cottontail rabbit papillomavirus genome in a retroviral vector. |
Q72583945 | Production of transgenic mice |
Q38646431 | Progress toward human gene therapy |
Q33920752 | Progress with retroviral gene vectors |
Q42808592 | Progression of rat embryo fibroblast cells immortalized with transforming genes of human papillomavirus type 16 |
Q72399477 | Prospects for Human Gene Therapy |
Q38237409 | Prospects for gene therapy now and in the future |
Q41302096 | Prospects for the control of AIDS patients by introducing defective-HIV harbouring leukocytes |
Q40851727 | Prospects for virus-based gene therapy for cystic fibrosis |
Q37371051 | Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice |
Q34047697 | Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy |
Q54374665 | Protection of uninfected human bone marrow cells in long-term culture from G418 toxicity after retroviral-mediated transfer of the NEOr gene. |
Q39376269 | Protective effect of gedunin on TLR-mediated inflammation by modulation of inflammasome activation and cytokine production: Evidence of a multitarget compound |
Q36254314 | Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors |
Q36552332 | Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene |
Q33928762 | Pseudotyped retroviral vectors reveal restrictions to reticuloendotheliosis virus replication in rat cells |
Q36687863 | Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range |
Q40036808 | Quantification and characterization of autotransduction in retroviral vector producer cells |
Q42663924 | R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions |
Q24617791 | RACH2, a novel human gene that complements a fission yeast cell cycle checkpoint mutation |
Q30054778 | RNA is a structural element in retrovirus particles |
Q38328360 | RNA packaging signal of human immunodeficiency virus type 1 |
Q41100836 | RNA packaging. |
Q41671801 | RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus |
Q35837228 | RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. |
Q35122730 | RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system. |
Q69799114 | RNA viruses as gene expression vectors |
Q42807566 | Rapid generation and flow cytometric analysis of stable GFP-expressing cells |
Q36808948 | Rapid titration of retroviral vectors encoding intracellular antigens by flow cytometry |
Q34304672 | Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines |
Q36560567 | Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events |
Q41195584 | Ras is involved in gap junction closure in proliferating fibroblasts or preadipocytes but not in differentiated adipocytes |
Q36075500 | Ras-independent transformation by v-Src |
Q34164036 | Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation |
Q41615398 | Rat cellular mutants for expression of mRNA from the long terminal repeat of murine retrovirus |
Q41537234 | Rat-1 fibroblasts engineered with GAD65 and GAD67 cDNAs in retroviral vectors produce and release GABA. |
Q36354503 | Rearrangement of exogenous immunoglobulin VH and DJH gene segments after retroviral transduction into immature lymphoid cell lines |
Q30334504 | Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology |
Q41319057 | Recombinant DNA technology: a 20-year occupational health retrospective |
Q69206990 | Recombinant gene expression in vivo within endothelial cells of the arterial wall |
Q38482437 | Recombinant hexahistidine arginine decarboxylase (hisADC) induced endogenous agmatine synthesis during stress |
Q41737027 | Recombinant neutral endopeptidase-24.11 expressed in mouse neuroblastoma cells is associated with neurite membranes |
Q35216664 | Recombinant retrovirus vectors for treatment of malignant brain tumors |
Q36874353 | Recombinant retroviruses encoding cell surface antigens as selectable markers. |
Q36912292 | Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens |
Q35610962 | Recombinant retroviruses that transduce individual polyoma tumor antigens: effects on growth and differentiation |
Q36872559 | Recombinant retroviruses that transduce middle T antigen cDNAs derived from polyomavirus mutants: separation of focus formation and soft-agar growth in transformation assays and correlations with kinase activities in vitro. |
Q39579989 | Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. |
Q74630606 | Reconstruction of SEA-B7.1 double signals on human hepatocellular carcinoma cells and analysis of its immunological effect |
Q36918698 | Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production |
Q45884752 | Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy |
Q44439368 | Regulated expression of HIV-1 Rev function in mammalian cell lines |
Q36835645 | Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector |
Q36802960 | Regulation of RNA splicing in gag-deficient mutants of Moloney murine sarcoma virus MuSVts110. |
Q41888711 | Regulation of natural antibody binding and susceptibility to natural killer cells through Zn++-inducibleras oncogene expression |
Q39504602 | Regulation of protein synthesis in virus-infected animal cells. |
Q35832832 | Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment |
Q43563690 | Regulation of the efficiency and thermodependence of murine sarcoma virus MuSVts110 RNA splicing by sequences in both exons |
Q41109063 | Release of replication-deficient retroviruses from a packaging cell line: interaction with glioma tumor spheroids in vitro |
Q28359721 | Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid |
Q30176895 | Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling |
Q36916742 | Rescue of type I collagen-deficient phenotype by retroviral-vector-mediated transfer of human pro alpha 1(I) collagen gene into Mov-13 cells |
Q36798367 | Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. |
Q34042038 | Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. |
Q37020060 | Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells |
Q37736716 | Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer |
Q48120641 | Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). |
Q41673599 | Retrotransposon gene engineering |
Q59350051 | Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly |
Q21131436 | Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why |
Q43905715 | Retroviral RNA packaging: sequence requirements and implications |
Q41703713 | Retroviral Vectors Related to the Myeloproliferative Sarcoma Virus Allow Efficient Expression in Hematopoietic Stem and Precursor Cell Lines, but Retroviral Infection Is Reduced in More Primitive Cells |
Q60160315 | Retroviral Vectors for Gene Transfer |
Q41857863 | Retroviral and lentiviral vectors for the induction of immunological tolerance |
Q33931883 | Retroviral characteristics of the long terminal repeat of murine E.Tn sequences |
Q68124839 | Retroviral envelope protein fusions to secreted and membrane markers |
Q42799011 | Retroviral expression of green fluorescent protein |
Q42952364 | Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity |
Q41719763 | Retroviral expression of transforming growth factor-alpha does not transform fibroblasts or keratinocytes |
Q45858285 | Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation |
Q41712927 | Retroviral gene therapy in hematopoietic diseases |
Q69145695 | Retroviral gene transfer in mice: the use of a unique packaging line improves efficiency |
Q40087583 | Retroviral gene transfer of tissue-type plasminogen activator targets thrombolysis in vitro and in vivo |
Q41751072 | Retroviral gene transfer using safe and efficient packaging cell lines |
Q41216939 | Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity |
Q45888976 | Retroviral mediated transfer and expression of human alpha 1-antitrypsin in cultured cells |
Q35848783 | Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. |
Q41640714 | Retroviral pseudotypes produced by rescue of a moloney murine leukemia virus vector by C-type, but not D-type, retroviruses |
Q35848344 | Retroviral retargeting by envelopes expressing an N-terminal binding domain. |
Q45035327 | Retroviral shuttle vectors as a tool for the study of mutational specificity (base substitution/deletion/mutational hotspot). |
Q73666855 | Retroviral transduction of murine epidermal stem cells demonstrates clonal units of epidermal structure |
Q33576574 | Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA. |
Q36752763 | Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia |
Q54405796 | Retroviral transfer and expression of the interleukin-3 gene in hemopoietic cells. |
Q40459592 | Retroviral transfer of HSV1-TK gene into human lung cancer cell line. |
Q34304914 | Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells |
Q33557828 | Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection |
Q35612715 | Retroviral transfer of genes into canine hemopoietic progenitor cells in culture: a model for human gene therapy |
Q36919339 | Retroviral vector gene expression in F9 embryonal carcinoma cells |
Q36288912 | Retroviral vector production in the National Gene Vector Laboratory at Indiana University |
Q39025649 | Retroviral vector production. |
Q43579547 | Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells |
Q68303284 | Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit |
Q41535083 | Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype |
Q73121669 | Retroviral vectors |
Q41465135 | Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression |
Q40405683 | Retroviral vectors displaying functional antibody fragments |
Q41744778 | Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. |
Q35216654 | Retroviral vectors for gene delivery to neural precursor cells |
Q35303194 | Retroviral vectors for persistent expression in vivo |
Q41751058 | Retroviral vectors for the beta-globin gene that demonstrate improved titer and expression |
Q40944434 | Retroviral vectors. From laboratory tools to molecular medicine |
Q38280077 | Retroviral vectors: from cancer viruses to therapeutic tools |
Q35261336 | Retroviral vectors: post entry events and genomic alterations |
Q52182771 | Retroviral-mediated expression of an MHC class I-restricted T cell receptor in the CD8 T cell compartment of bone marrow-reconstituted mice. |
Q37593042 | Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy |
Q37915230 | Retroviral-mediated gene transfer |
Q33663979 | Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes |
Q35586549 | Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells |
Q28576254 | Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth |
Q41555361 | Retroviral-mediated gene transfer of the porcine choline acetyltransferase: a model to study the synthesis and secretion of acetylcholine in mammalian cells. |
Q39338569 | Retroviral-mediated gene transfer. Applications in neurobiology |
Q34614384 | Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein |
Q35604723 | Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow |
Q36597697 | Retrovirus RNA trafficking: from chromatin to invasive genomes |
Q36980900 | Retrovirus Transduction: Generation of Infectious Retroviruses Expressing Dominant and Selectable Genes Is Associated with In Vivo Recombination and Deletion Events |
Q39650796 | Retrovirus mediated gene transfer into hemopoietic cells |
Q41724194 | Retrovirus mediated transfer and expression of GM-CSF in haematopoietic cells |
Q40811299 | Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer system |
Q37784715 | Retrovirus packaging cells. |
Q36682583 | Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells |
Q36915374 | Retrovirus shuttle vector for study of kinase activities of pp60c-src synthesized in vitro and overproduced in vivo |
Q51239419 | Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. |
Q41719716 | Retrovirus vector-targeted inducible expression of human beta-interferon gene to B-cells. |
Q39584235 | Retrovirus vectors and their applications in neurobiology |
Q39763606 | Retrovirus vectors and their uses in molecular biology |
Q40115867 | Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration |
Q73876718 | Retrovirus vectors displaying the IgG-binding domain of protein A |
Q36457016 | Retrovirus vectors: toward the plentivirus? |
Q71787203 | Retrovirus-Mediated Transduction of an Engineered Intron-Containing Purine Nucleoside Phosphorylase Gene |
Q39214743 | Retrovirus-based mRNA transfer for transient cell manipulation |
Q36221025 | Retrovirus-mediated expression of preprosomatostatin: posttranslational processing, intracellular storage, and secretion in GH3 pituitary cells |
Q40396909 | Retrovirus-mediated gene transfer in cancer therapy |
Q39696578 | Retrovirus-mediated gene transfer into hematopoietic stem cells. |
Q41080907 | Retrovirus-mediated gene transfer into rat salivary gland cells in vitro and in vivo |
Q41214784 | Retrovirus-mediated gene transfer into salivary glands in vivo |
Q40671349 | Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo |
Q41545589 | Retrovirus-mediated gene transfer of transthyretin and transthyretin-methionine 30: a potential tool for the study of amyloidogenesis |
Q45878998 | Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain |
Q34319023 | Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. |
Q34983618 | Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations |
Q33570031 | Retrovirus-mediated transduction of adult hepatocytes |
Q45889908 | Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells |
Q36766745 | Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder |
Q35600024 | Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo |
Q41876682 | Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: Specific domain functions in keratin stabilization and filament formation |
Q40906270 | Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cells |
Q35034076 | Retroviruses as genetic tools to isolate transcriptionally active chromosomal regions |
Q45866942 | RevM10-Mediated Inhibition of HIV-1 Replication in Chronically Infected T Cells |
Q42617430 | Reverse transcription and packaging of hepatitis B virus (HBV)—RNA generates in vivo defective serum HBV particles |
Q36900833 | Reverse transcription of 7S L RNA by an avian retrovirus |
Q34354654 | Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro |
Q40971997 | Ribosomal frameshifting in yeast viruses. |
Q36697793 | Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice |
Q36796100 | Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein |
Q36818661 | Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells |
Q69110537 | Role of the c-myc and the N-myc proto-oncogenes in the immortalization of neural precursors |
Q40984080 | Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis |
Q36853856 | Roles of helper and defective retroviral genomes in murine erythroleukemia: studies of spleen focus-forming virus in the absence of helper |
Q42816290 | Rous sarcoma virus encodes a transcriptional activator |
Q34618023 | Rous sarcoma virus is integrated but not expressed in chicken early embryonic cells |
Q45755448 | S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. |
Q42809173 | SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen |
Q33644899 | Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges |
Q37219609 | Safety Issues Related to Retroviral-Mediated Gene Transfer in Humans |
Q36090110 | Safety aspects of gene therapy |
Q42467354 | Schwann cells infected with a recombinant retrovirus expressing myelin-associated glycoprotein antisense RNA do not form myelin |
Q37527910 | Scientific and ethical considerations in human gene therapy |
Q40139360 | Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins |
Q40038005 | Screening retroviral packaging cells for highly efficient virus production by using a combined selection procedure |
Q37565230 | Secretion of human parathyroid hormone from rat pituitary cells infected with a recombinant retrovirus encoding preproparathyroid hormone |
Q45888762 | Selection for phenylalanine hydroxylase activity in cells transformed with recombinant retroviruses |
Q35857245 | Selective and nonselective packaging of cellular RNAs in retrovirus particles |
Q42805402 | Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression |
Q21245112 | Selective gene silencing by viral delivery of short hairpin RNA |
Q41287985 | Selective loss of H-2Ds antigen on a murine B lymphoma due to a post-transcriptional block in expression |
Q35604467 | Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells |
Q36785737 | Separation of simian virus 40 large-T-antigen-transforming and origin-binding functions from the ability to block differentiation |
Q39581452 | Sequences in pol are required for transfer of human foamy virus-based vectors. |
Q40132598 | Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses |
Q36652108 | Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the psi-gag-PR region |
Q38355080 | Sequences within both the 5′ untranslated region and the Gag gene are important for efficient encapsidation of Mason–Pfizer monkey virus RNA |
Q45886049 | Severe combined immunodeficiencies and related disorders |
Q42799992 | Shuttle vector system for the analysis of mutational events in mammalian chromosomal DNA. |
Q40132184 | Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector |
Q36645412 | Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles |
Q40809732 | Simian retrovirus vectors for gene transfer in nonhuman primate cells |
Q36690671 | Simian virus 40 large T-antigen expression decreases the G1 and increases the G2 + M cell cycle phase durations in exponentially growing cells |
Q33812137 | Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function |
Q41655587 | Simple system for isolation of cellular and viral mutants for transformation by retrovirus |
Q54593726 | Simplified plasmid rescue of host sequences adjacent to integrated proviruses. |
Q42991441 | Sindbis virus: an efficient, broad host range vector for gene expression in animal cells |
Q53538979 | Single-base mutations associated with mouse lymphomas. |
Q33825579 | Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons |
Q68354939 | Site-specific gene expression in vivo by direct gene transfer into the arterial wall |
Q30372344 | Site-specific mutagenesis identifies amino acid residues critical in prohormone processing. |
Q37224218 | Somatic Gene Therapy |
Q39752255 | Somatic gene therapy for human disease: background and prospects. Part I. |
Q40922217 | Somatic gene therapy. Current status and future prospects |
Q42796214 | Species specificity of interleukin 2 binding to individual receptor components |
Q36655093 | Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays |
Q59078565 | Specific growth response of ras-transformed embryo fibroblasts to tumour promoters |
Q38288423 | Specific packaging of spliced retroviral vector transcripts lacking the Psi-region |
Q42805869 | Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells |
Q36699497 | Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging |
Q36687788 | Specificity of retroviral RNA packaging |
Q36797695 | Spleen necrosis virus, an avian retrovirus, can infect primate cells |
Q45522377 | Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection |
Q72720016 | Spontaneous dimerization of retroviral MoMuLV RNA |
Q43842361 | Stability of retrovirally transduced markers in a rat cell line |
Q35134462 | Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors |
Q41577351 | Stable expression of antibiotic resistance genes using a promoter fragment of the U1 snRNA gene |
Q41523293 | Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer |
Q41285166 | Stable overexpression of human HSF-1 in murine cells suggests activation rather than expression of HSF-1 to be the key regulatory step in the heat shock gene expression |
Q64379700 | Stable transfer of a mouse dihydrofolate reductase gene into a deficient cell line using human adenovirus vector |
Q40649557 | Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells |
Q35832690 | Stem cell factor binding to retrovirus primer binding site silencers |
Q42825002 | Streptavidin-based quantitative staining of intracellular antigens for flow cytometric analysis |
Q42813481 | Stromal cell-dependent growth of leukemic cells from murine erythroblastic leukemia |
Q39553977 | Structural and functional studies of protein kinase C. |
Q28285434 | Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus |
Q27656384 | Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy |
Q37974642 | Structural dynamics of retroviral genome and the packaging |
Q35832727 | Structural interactions between retroviral Gag proteins examined by cysteine cross-linking |
Q34185507 | Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector |
Q36864676 | Structure and transforming function of transduced mutant alleles of the chicken c-myc gene |
Q27664955 | Structure of a Conserved Retroviral RNA Packaging Element by NMR Spectroscopy and Cryo-Electron Tomography |
Q42818953 | Studies on compartmentation and turnover of murine retrovirus envelope proteins |
Q35765188 | Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124. |
Q33818725 | Suicide genes: past, present and future perspectives |
Q40935159 | Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells |
Q40928382 | Suppression of anchorage-independent growth of human cancer cell lines by the drs gene |
Q34597099 | Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin |
Q34340811 | Suppression of heat-induced hsp70 expression by the 70-kDa subunit of the human Ku autoantigen |
Q41407134 | Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells |
Q32099220 | Suppression of v-src transformation by the drs gene |
Q36485425 | Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms |
Q69737071 | Surface expression of the T cell receptor complex requires charged residues within the alpha chain transmembrane region |
Q41686665 | Survival and differentiation within the adult mouse striatum of grafted rat pheochromocytoma cells (PC12) genetically modified to express recombinant beta-NGF. |
Q41662310 | Survival period of tumor-bearing mice is prolonged after the interferon-gamma-producing gene transfer |
Q33932705 | Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus |
Q45866838 | T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. |
Q43976877 | TGF alpha stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression |
Q24594918 | Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes |
Q48792700 | Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells |
Q45069562 | Targeting and processing of pro-opiomelanocortin in neuronal cell lines |
Q34365155 | Targeting of retroviral vectors for gene therapy |
Q36232783 | Targeting of the "insulin-responsive" glucose transporter (GLUT4) to the regulated secretory pathway in PC12 cells |
Q38326676 | Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion |
Q30466758 | Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. |
Q28592095 | Tetracysteine-tagged prion protein allows discrimination between the native and converted forms |
Q36768150 | The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc |
Q42807418 | The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts |
Q36700906 | The Ets-related transcription factor PU.1 immortalizes erythroblasts |
Q36564631 | The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter |
Q29618472 | The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain |
Q40041446 | The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. |
Q41534206 | The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells |
Q36732985 | The amino-terminal 14 amino acids of v-src can functionally replace the extracellular and transmembrane domains of v-erbB |
Q41693495 | The amino-terminal 147 amino acids of SV40 large T antigen transform secondary rat embryo fibroblasts |
Q24654115 | The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences |
Q39406282 | The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056 |
Q37350126 | The application of viral vectors to enhance regeneration after peripheral nerve repair. |
Q33783331 | The bovine leukemia virus encapsidation signal is composed of RNA secondary structures. |
Q28301200 | The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene |
Q33929830 | The bovine leukemia virus p34 is a transactivator protein |
Q36787130 | The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus |
Q34591671 | The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag. |
Q39881014 | The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex |
Q31014896 | The cultural mouse |
Q36332163 | The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction |
Q41523285 | The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance |
Q37535778 | The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer. |
Q35832442 | The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure. |
Q41716342 | The electrogenic sodium bicarbonate cotransporter: developmental expression in rat brain and possible role in acid vulnerability. |
Q24675131 | The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species |
Q28513922 | The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 |
Q45837892 | The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis |
Q40077796 | The genetics of murine leukemia viruses. |
Q41617860 | The hepatocyte-specific phenotype of murine liver cells correlates with high expression of connexin32 and connexin26 but very low expression of connexin43 |
Q24682817 | The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures |
Q34434755 | The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure |
Q33929960 | The in vitro behavior of hemopoietic cells transformed by polyoma middle T antigen parallels that of primary human myeloid leukemic cells |
Q34633466 | The inside out of lentiviral vectors |
Q36828053 | The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage |
Q35034033 | The malignant conversion step of mouse skin carcinogenesis |
Q36918582 | The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. |
Q28291337 | The metanephric blastema differentiates into collecting system and nephron epithelia in vitro |
Q34258836 | The molecular genetics of human hemoglobin |
Q45804450 | The nucleotide sequence of the Akv murine leukemia virus genome |
Q35866801 | The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses |
Q36828275 | The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. |
Q41760092 | The primary structure of major viral RNA in a rat cell line transfected with type 47 human papillomavirus DNA and the transforming activity of its cDNA and E6 gene |
Q36220522 | The propeptide of preprosomatostatin mediates intracellular transport and secretion of alpha-globin from mammalian cells |
Q33919776 | The proto-oncogene int-1 encodes a secreted protein associated with the extracellular matrix |
Q33846535 | The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors |
Q28569479 | The rat interleukin-5 gene: Characterization and expression by retroviral gene transfer and polymerase chain reaction |
Q36687255 | The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus |
Q38185388 | The role of growth factors in normal and neoplastic haemopoiesis |
Q36906696 | The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion |
Q42819692 | The thymidine kinase/ganciclovir-mediated "suicide" effect is variable in different tumor cells |
Q34050744 | The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation |
Q33836887 | The two subunits of the human asialoglycoprotein receptor have different fates when expressed alone in fibroblasts |
Q67282722 | The use of a retroviral vector to identify foetal striatal neurones transplanted into the adult striatum |
Q41661372 | The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum |
Q44018943 | The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line |
Q36839863 | The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. |
Q53511722 | The v-ras oncogene inhibits the expression of differentiation markers and facilitates expression of cytokeratins 8 and 18 in mouse keratinocytes |
Q45882944 | The vascular endothelial cell as a vehicle for gene therapy |
Q48587406 | Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells |
Q70338863 | Tissue-specific expression of functionally rearranged lambda 1 Ig gene through a retrovirus vector |
Q41428152 | Tissue-specific targeting of retroviral vectors through ligand-receptor interactions |
Q73850541 | To fuse or not to fuse: the effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilization |
Q70472317 | Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors |
Q34450066 | Transcriptional Silencing of Retroviral Vectors. |
Q36795776 | Transduction of cellular neo mRNA by retrovirus-mediated recombination |
Q33929116 | Transduction of host cellular sequences by a retroviral shuttle vector |
Q36761058 | Transduction of human colony-stimulating factor-1 (CSF-1) receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth |
Q43898723 | Transfection of a DNA/protein complex into nuclei of mammalian cells using polyoma capsids and electroporation |
Q37249173 | Transfer and expression of the human multiple drug resistance gene into live mice |
Q40344036 | Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein |
Q45149175 | Transfer of functional EGF receptors to an IL3-dependent cell line |
Q41384774 | Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter |
Q37672708 | Transfer of genes into hematopoietic cells using recombinant DNA viruses |
Q24683087 | Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site |
Q41462810 | Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. |
Q42806558 | Transformation by oncogenes encoding protein kinases induces the metastatic phenotype |
Q53551047 | Transformation mediated by the SV40 T antigens: separation of the overlapping SV40 early genes with a retroviral vector. |
Q38344538 | Transformation of NIH 3T3 fibroblasts by an activated form of p59hck |
Q41687212 | Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenes |
Q33682660 | Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein |
Q41760172 | Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment |
Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
Q45864350 | Transgene expression and RNA interference in embryonic stem cells |
Q48910622 | Transgene expression in zebrafish: A comparison of retroviral-vector and DNA-injection approaches |
Q37409515 | Transgenesis by means of blastocyst-derived embryonic stem cell lines |
Q74440357 | Transgenic Technology and Laboratory Animal Science |
Q69352129 | Transgenic animals |
Q70168226 | Transgenic chickens: insertion of retroviral genes into the chicken germ line |
Q36739755 | Translational considerations for CNS gene therapy |
Q71624177 | Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle |
Q40781409 | Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats |
Q40952232 | Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. |
Q36793262 | Transport and assembly of gag proteins into Moloney murine leukemia virus |
Q35573405 | Treatment of autoimmune disease by adoptive cellular gene therapy |
Q41657338 | Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. |
Q92457503 | Truncated oncoproteins of retroviruses and hepatitis B virus: A lesson in contrasts |
Q36230110 | Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer |
Q35984403 | Tumour suppression associated with expression of human insulin-like growth factor II. |
Q69636010 | Turnover and compartmentation of gp70/p15 E in psi 2 cells |
Q36918548 | Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells |
Q33662050 | Two dominant-acting selectable markers for gene transfer studies in mammalian cells |
Q37674587 | Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma |
Q46849388 | Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining |
Q41744094 | Two subfamilies of murine retrotransposon ETn sequences |
Q41484320 | Two-dimensional gel mapping of small GTPases reveals transformation-specific changes during oncogenesis |
Q44049774 | Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src |
Q36687162 | U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses |
Q27313711 | UNC93B1 mediates host resistance to infection with Toxoplasma gondii |
Q36905035 | Unusual features of the leader sequence of Rous sarcoma virus packaging mutant TK15 |
Q48313396 | Unusual immunoglobulin gene rearrangement leads to replacement of recombinational signal sequences |
Q60160340 | Use of Retroviral Vectors for Gene Transfer and Expression |
Q33880924 | Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos |
Q29620166 | Use of eukaryotic expression technology in the functional analysis of cloned genes |
Q41586156 | Use of multidrug resistance gene in mammalian expression vectors |
Q36869583 | Use of recombinant retroviruses to study the regulation of integrated adenovirus early promoters |
Q41582824 | Use of retroviral vectors for gene transfer and expression |
Q42643989 | V(D)J recombination of chromosomally integrated, wild-type deletional and inversional substrates occur at similar frequencies with no preference for orientation |
Q36901149 | Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs |
Q41430840 | Vinculin-deficient PC12 cell lines extend unstable lamellipodia and filopodia and have a reduced rate of neurite outgrowth |
Q40504840 | Viral RNA annealing activities of the nucleocapsid protein of Moloney murine leukemia virus are zinc independent |
Q38661287 | Viral Vectors for Gene Therapy: Translational and Clinical Outlook |
Q36821051 | Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses |
Q89656152 | Viral approaches to study the mammalian brain: Lineage tracing, circuit dissection and therapeutic applications |
Q35210466 | Viral therapy for glioblastoma |
Q34836871 | Virus-based gene delivery systems |
Q37825015 | Viruses as vectors |
Q33277347 | Widespread Dispersion of Neuronal Clones Across Functional Regions of the Cerebral Cortex |
Q62397562 | [72] Identification of regulatory elements of cloned genes with functional assays |
Q24319116 | bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy |
Q33919315 | bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. |
Q33958488 | c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points |
Q40107854 | cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. |
Q36910202 | cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus |
Q34338573 | cis-Acting elements important for retroviral RNA packaging specificity |
Q33783544 | cis-Acting sequences required for simian foamy virus type 1 vectors |
Q36695651 | cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. |
Q35865815 | cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA. |
Q40847872 | p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo |
Q40409057 | p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells |
Q41502371 | p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells |
Q43647683 | pp60(c-src) modulates microvascular endothelial phenotype and in vitro angiogenesis |
Q71974461 | pp60c-src is required for the induction of a quiescent mesangial cell phenotype |
Q36759826 | pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527. |
Q36530992 | pp60src tyrosine kinase modulates P19 embryonal carcinoma cell fate by inhibiting neuronal but not epithelial differentiation |
Q36791062 | ras effector loop mutations that dissociate p120GAP and neurofibromin interactions |
Q39873362 | trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. |
Q54948492 | Psi-2 | described by source | P1343 |
Search more.